Ftse Mib
33.641,96
-0,28%
DAX
18.001,60
0,54%
S&P 500
5.134,31
1,38%
NASDAQ
16.175,10
2,11%
Bitcoin
61.756,19
4,46%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Arch Therapeutics Inc (QB) (ARTH) Arch Therapeutics Inc (QB) (ARTH) Notizie

ARTH

Arch Therapeutics (QB) (ARTH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ARTH
DataOraFonteTitoloSimboloCompagnia
22/06/202322:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
23/05/202312:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
16/05/202312:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHArch Therapeutics Inc (QB)
25/01/202321:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHArch Therapeutics Inc (QB)
23/01/202323:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202222:52Edgar (US Regulatory)Annual Report (10-k)USOTC:ARTHArch Therapeutics Inc (QB)
31/08/202212:05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202223:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202212:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARTHArch Therapeutics Inc (QB)
22/08/202212:04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARTHArch Therapeutics Inc (QB)
18/08/202212:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARTHArch Therapeutics Inc (QB)
17/08/202222:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202222:24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/202223:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
22/03/202210:14TipRanksDawson James Remains a Buy on Arch Therapeutics (ARTH)USOTC:ARTHArch Therapeutics Inc (QB)
04/01/202222:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202122:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ARTHArch Therapeutics Inc (QB)
22/12/202122:08Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ARTHArch Therapeutics Inc (QB)
25/02/202118:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARTHArch Therapeutics Inc (QB)
17/10/201923:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:ARTHArch Therapeutics Inc (QB)
20/07/201819:15Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ARTHArch Therapeutics Inc (QB)
17/11/201619:35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201622:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ARTHArch Therapeutics Inc (QB)
16/07/201614:00InvestorsHub NewsWireInsider Financial Publishes New Research On Three Promising BiotechsUSOTC:ARTHArch Therapeutics Inc (QB)
14/07/201614:33InvestorsHub NewsWireOne Step Vending Corp. KOSK – 230% Growth and Over 150,000 Units SuppliedUSOTC:ARTHArch Therapeutics Inc (QB)
14/10/201512:03Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARTHArch Therapeutics Inc (QB)
16/06/201414:15MarketwiredArch Therapeutics Co-Founder Rutledge Ellis-Behnke to Speak at European Summit for Clinical Nanomedicine & Targeted Medicine ...USOTC:ARTHArch Therapeutics Inc (QB)
28/05/201415:00MarketwiredArch Therapeutics Inc. to Present at the LD MICRO Invitational 2014 on June 4thUSOTC:ARTHArch Therapeutics Inc (QB)
27/05/201415:00MarketwiredArch Therapeutics Inc. to Present at the Third Annual Marcum MicroCap ConferenceUSOTC:ARTHArch Therapeutics Inc (QB)
01/04/201414:00MarketwiredArch Therapeutics Appoints Chirag Shah, PhD as Vice President of R&D Engineering & Quality Systems & Peter LaCrosse as Chief ...USOTC:ARTHArch Therapeutics Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ARTH

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network